Feature

Interactive tool clarifies breast density risks without causing ‘undue anxiety’ after mammogram

January 28, 2020
Dense breast tissue is a common phenomenon, apparent in half of women who undergo screening mammography. Most states require that mammogram reports…

Feature

Researchers aim to personalize chemotherapy for black patients with breast cancer

January 27, 2020
Racial disparities in cancer care and outcomes have been well-documented. However, not all challenges black patients with breast cancer face stem…

Point/Counter

Will liquid biopsies be used routinely to screen for cancer?

HemOnc Today, January 25, 2020
POINT Genomic analysis of plasma cfDNA has been adopted widely in the care of patients with cancer. Indeed, the rapid and widespread adoption is striking…

Cover Story

Oncologists must be ‘very cautious’ as liquid biopsy use expands

HemOnc Today, January 25, 2020
So-called “liquid biopsies” — noninvasive tests used to evaluate blood for cancer cells or DNA — have been refined…

Feature

Obesity linked to worse psychosocial outcomes among patients with breast, prostate cancer

January 20, 2020
The physical symptoms of cancer often are accompanied by equally profound psychosocial struggles. Most patients with cancer grapple with some degree…

In the Journals

Antioxidant supplements linked to increased risk for breast cancer recurrence, death

January 16, 2020
Use of antioxidant supplements during chemotherapy, as well as iron and vitamin B12, by patients with breast cancer may increase their risk for…

Feature

Internet popularity does not equal success for cancer awareness campaigns

January 15, 2020
In the age of digital communication, clicks, views and “likes” can be valuable measures of the visibility and reach of health awareness…

In the Journals

Partial breast reirradiation ‘viable alternative to mastectomy’ for certain women with breast cancer recurrence

January 10, 2020
Partial breast reirradiation without mastectomy appeared as effective as mastectomy for treatment of breast cancer recurrence in the ipsilateral…

In the JournalsPerspective

Health coverage mediates risk for later-stage breast cancer diagnosis among minorities

January 9, 2020
Health insurance coverage mediated almost half of upstaging at breast cancer diagnosis among a population of racial and ethnic minority women…

In the JournalsPerspective

Cancer mortality rate drops 29% between 1991 and 2017

January 8, 2020
Cancer mortality rates dropped by 29% between 1991 and 2017 in the United States, with a 2.2% drop between 2016 and 2017, according to according to…

$1 million grants fund research into melanoma metastasis

January 4, 2020
American Cancer Society and Melanoma Research Alliance provided two $1 million grants that will fund research focused on metastasis of melanoma and…

In the Journals

Cancer survivors may have increased CVD mortality risk

December 29, 2019
Patients who survived cancer have an increased risk for mortality from CHD and stroke compared with the general population, according to a study…

In the Journals

Obese women with breast cancer at elevated risk for cardiotoxicity

December 27, 2019
Patients with breast cancer treated with anthracyclines and/or trastuzumab who are also obese have significantly greater incidence of risk-related…

Cover Story

Cancer drug doses: More is not always better

HemOnc Today, December 25, 2019
Historically, the goal of cancer treatment has been to destroy as many cancer cells as possible through chemotherapy or radiation. Guided by this…

FDA News

FDA approves Enhertu for HER2-positive breast cancer

December 21, 2019
The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki for the treatment of adults with unresectable or metastatic HER2-positive…

Meeting NewsPerspective

Oral paclitaxel regimen improves outcomes vs. IV formulation in metastatic breast cancer

December 20, 2019
SAN ANTONIO — A novel combination of oral paclitaxel plus encequidar significantly improved overall response rates compared with IV paclitaxel…

Meeting NewsPerspective

Circulating tumor DNA predicts recurrence in early-stage triple-negative breast cancer

December 19, 2019
SAN ANTONIO — Detection of circulating tumor DNA after neoadjuvant chemotherapy appeared to independently predict disease recurrence among…

FDA News

FDA grants breakthrough therapy designation to tucatinib for advanced breast cancer

December 18, 2019
The FDA granted breakthrough therapy designation to tucatinib in combination with trastuzumab and capecitabine for the treatment of locally advanced…

In the Journals

Sustained weight loss lowers risk for breast cancer

December 17, 2019
Women aged 50 years and older who had sustained weight loss over more than 8 years demonstrated a decreased risk for breast cancer compared with…

Meeting NewsPerspective

Anastrozole provides long-term preventive effect for postmenopausal women at high risk for breast cancer

December 16, 2019
SAN ANTONIO — Anastrozole reduced breast cancer risk by 49% compared with placebo for postmenopausal women at high risk for the disease…